InvestorsHub Logo
Followers 77
Posts 30218
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Friday, 04/07/2023 9:57:21 PM

Friday, April 07, 2023 9:57:21 PM

Post# of 447
>>> Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty

Business Wire

March 30, 2023

First clinical use of Stryker’s Tornier Pyrocarbon Humeral Head completed at Denver Surgery Center in Colorado

DENVER, March 30, 2023--(BUSINESS WIRE)--Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that Armodios M. Hatzidakis, MD, FAAOS, Western Orthopaedics, PC, Denver Surgery Center and Rose Medical Center, has successfully completed the first case in the United States, since the De Novo clearance, using the Tornier Pyrocarbon Humeral Head. Stryker’s De Novo request was granted in late 2022 after completing an Investigational Device Exemption (IDE) study with the FDA.

Stryker's Tornier Pyrocarbon Humeral Head is the first FDA-cleared pyrocarbon implant for shoulder hemiarthroplasty in the U.S.

"Historically, joint replacement surgery for younger patients with severe shoulder arthritis has been challenging, with a high early failure risk due to socket component loosening," said Dr. Hatzidakis, the primary investigator for the IDE. "I'm very pleased with the results my patients in the clinical trial have had with Stryker’s Tornier Pyrocarbon Humeral Head, including those with up to seven years of follow up. It’s encouraging to have an alternative for patients without the risk of socket component loosening."

Pyrocarbon is an advanced bearing material that has surface properties more similar to bone than traditional orthopaedic metallic bearing surfaces. It has been utilized internationally for a variety of orthopaedic procedures since the early 1990s and in shoulder cases since 2013. Stryker is the first company to offer an FDA-cleared pyrocarbon implant for shoulder hemiarthroplasty in the U.S.

"As a global leader in shoulder arthroplasty, we are excited to bring this technology to the United States," said Tim Lanier, vice president and general manager, Upper Extremities, Stryker. "Dr. Hatzidakis’ first clinical usage of the Pyrocarbon Humeral Head for shoulder hemiarthroplasty is another milestone demonstrating our drive to provide new options for shoulder surgeons and their patients and make healthcare better."

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.